Clinical Trials Browser

Stomach Neoplasms × olaparib × 90 days × Clear all

NCT05379972 2026-06-05

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

Phase 2 Completed

9 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms

NCT02734004 2026-04-20

MEDIOLA

Phase 1/2 Active not recruiting

264 enrolled 32 charts

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma